BB&T Securities LLC Increases Stock Position in Agilent Technologies Inc (NYSE:A)


BB&T Securities LLC raised its holdings in shares of Agilent Technologies Inc (NYSE:A) by 2.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,172 shares of the medical research company’s stock after buying an additional 248 shares during the quarter. BB&T Securities LLC’s holdings in Agilent Technologies were worth $759,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in A. Stratos Wealth Partners LTD. boosted its position in shares of Agilent Technologies by 2.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 31,792 shares of the medical research company’s stock valued at $2,555,000 after acquiring an additional 850 shares during the last quarter. Prentiss Smith & Co. Inc. boosted its position in shares of Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock valued at $4,363,000 after acquiring an additional 48,438 shares during the last quarter. TimesSquare Capital Management LLC boosted its position in shares of Agilent Technologies by 0.7% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,007,700 shares of the medical research company’s stock valued at $80,999,000 after acquiring an additional 7,200 shares during the last quarter. Nordea Investment Management AB boosted its position in shares of Agilent Technologies by 510.5% during the 1st quarter. Nordea Investment Management AB now owns 112,292 shares of the medical research company’s stock valued at $9,028,000 after acquiring an additional 93,898 shares during the last quarter. Finally, Mason Street Advisors LLC boosted its position in shares of Agilent Technologies by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 45,312 shares of the medical research company’s stock valued at $3,642,000 after acquiring an additional 370 shares during the last quarter.

A has been the topic of several recent research reports. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Piper Jaffray Companies boosted their price target on shares of Agilent Technologies from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, August 15th. Needham & Company LLC upped their target price on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price on the stock. in a research report on Tuesday, July 16th. Finally, Wolfe Research initiated coverage on shares of Agilent Technologies in a research report on Thursday, May 30th. They issued a “peer perform” rating on the stock. Six equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $84.77.

In other news, Director Heidi Fields sold 4,000 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $70.96, for a total transaction of $283,840.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.

NYSE A traded up $0.27 during trading hours on Friday, reaching $77.84. The company had a trading volume of 223,782 shares, compared to its average volume of 2,491,547. The stock has a market capitalization of $23.14 billion, a P/E ratio of 27.91, a price-to-earnings-growth ratio of 2.07 and a beta of 1.40. Agilent Technologies Inc has a 1-year low of $61.01 and a 1-year high of $82.27. The company has a current ratio of 2.13, a quick ratio of 1.72 and a debt-to-equity ratio of 0.27. The stock has a 50-day moving average of $70.28 and a 200 day moving average of $73.97.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.04. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.67 earnings per share. As a group, sell-side analysts predict that Agilent Technologies Inc will post 3.08 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Initial Coin Offering (ICO)

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here